Linamet 2.5 mg+1000 mg (Tablet)
Unit Price: ৳ 16.00 (2 x 10: ৳ 320.00)
Strip Price: ৳ 160.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Linagliptin metformin hydrochloride |
| Company | Popular pharmaceuticals ltd |
| Also available as |
Indications
- Adjunct to diet and exercise
- Improves glycemic control
- Type 2 diabetes mellitus
Pharmacology
- Inhibitor of DPP-4 enzyme
- Increases insulin release
- Decreases glucagon secretion
- Biguanide type oral antihyperglycemic drug
- Lowers plasma glucose
- Improves insulin sensitivity
Dosage & Administration
- Individualized dosage
- Maximum recommended dose
- Dose escalation
- Immediate release tablet
- Extended release tablet
- Recommended starting dose
Interaction
- Cationic Drugs interaction
- Carbonic Anhydrase Inhibitors interaction
- Inducers of P-glycoprotein and CYP3A4 Enzymes interaction
- Drugs Affecting Glycemic Control interaction
Contraindications
- Renal impairment
- Metabolic acidosis
- Hypersensitivity
Side Effects
- Nasopharyngitis
- Diarrhea
- Hypoglycemia
Pregnancy & Lactation
- Use during pregnancy if clearly needed
- Caution during lactation
Precautions & Warnings
- Discontinue in lactic acidosis
- Discontinue if pancreatitis suspected
- Discontinue in certain medical procedures
- Monitor Vitamin B12 levels
- Symptoms of lactic acidosis
- Alcohol precautions
- Medicine interactions precautions
- Counseling precautions
- Travel precautions
- Emergency preparedness
- Hypoglycemia precautions
Overdose Effects
- Supportive measures for overdose
- Hemodialysis or peritoneal dialysis unlikely for Linagliptin
- Dialyzable for Metformin Hydrochloride
- Clinical monitoring for Linagliptin
- No dose-related clinical adverse drug reactions for Linagliptin
- Potential hypoglycemia and lactic acidosis for Metformin Hydrochloride overdose
Therapeutic Class
- Combination Oral hypoglycemic preparations
Storage Conditions
- Cool & dry place
- Below 30°C
- Protected from light & moisture
- Keep out of reach of children